Last $1.93 USD
Change Today +0.028 / 1.47%
Volume 56.8K
DSCO On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 11:10 AM 04/21/14 All times are local (Market data is delayed by at least 15 minutes).

discovery laboratories inc (DSCO) Key Developments

Discovery Laboratories Inc. Announces Management Appointments

Discovery Laboratories Inc. announced new appointments to the company's management team. William C. Roberts has joined the company as Vice President, Investor Relations and Corporate Communications. In addition, John A. Tattory has been appointed Senior Vice President and Chief Financial Officer. Both Mr. Roberts and Mr. Tattory will report to John G. Cooper, President and Chief Executive Officer. Prior to joining the company, Mr. Roberts spent ten years with ViroPharma Incorporated (recently acquired by Shire), most recently serving as Vice President, Corporate Communications, with responsibility for investor and media relations, patient and physician advocacy, disease awareness, and commercial support. Previously, Mr. Roberts spent 12 years with MedImmune Inc. in various scientific and investor relations roles of increasing responsibility. Mr. Tattory joined Discovery Labs in 2008 and has served since then as Vice President, Finance. Mr. Tattory is a Certified Public Accountant with more than 20 years of finance and accounting experience, including eight years with Ernst & Young LLP and eight years with Bristol-Myers Squibb (BMS).

Discovery Laboratories Inc. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013; Provides Operating Cash Outflows Guidance for the First Quarter of 2014

Discovery Laboratories Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter ended December 31, 2013, the company reported grant revenue of $74,000 against $195,000 for the same period a year ago. Operating loss was $10,265,000 against $12,425,000 for the same period a year ago. Net loss was $11,729,000 or $0.16 loss per common share against $6,815,000 or $0.16 loss per common share for the same period a year ago. For the full year, the company reported grant revenue of $388,000 against $195,000 for the same period a year ago. Operating loss was $44,508,000 against $37,819,000 for the same period a year ago. Net loss was $45,215,000 or $0.82 loss per common share against $37,315,000 or $0.95 loss per common share for the same period a year ago. For the first quarter of 2014, the company anticipates operating cash outflows before financing activities of approximately $11 million.

Discovery Laboratories Inc., Q4 2013 Earnings Call, Mar 13, 2014

Discovery Laboratories Inc., Q4 2013 Earnings Call, Mar 13, 2014

Discovery Laboratories Inc. to Report Q4, 2013 Results on Mar 13, 2014

Discovery Laboratories Inc. announced that they will report Q4, 2013 results at 9:00 AM, Eastern Standard Time on Mar 13, 2014

Discovery Laboratories Inc. Presents at 25th Annual Piper Jaffray Healthcare Conference 2013, Dec-03-2013 01:10 PM

Discovery Laboratories Inc. Presents at 25th Annual Piper Jaffray Healthcare Conference 2013, Dec-03-2013 01:10 PM. Venue: The New York Palace Hotel, 455 Madison Avenue, New York, NY 10022, United States.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DSCO:US $1.93 USD +0.028

DSCO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $38.46 USD -0.47
View Industry Companies
 

Industry Analysis

DSCO

Industry Average

Valuation DSCO Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 358.1x
Price/Book 2.7x
Price/Cash Flow NM Not Meaningful
TEV/Sales 144.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DISCOVERY LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.